Amgen Inc.

(AMGN) Trade

By |

Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Contact Information

Website: www.amgen.com
Email: investor.relations@amgen.com
Main Phone: +1 805 447-1000
Address: One Amgen Center Drive
Address 2: Suite 2650
State: CA
City / Town: Thousand Oaks
Country: USA
Postal Code: 91320-1799

Issuer Information

Exchange: NGS
CEO: Robert A. Bradway
Employees: 20800
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
$ 193.92 $ -0.96 (-0.49%)
Last Price 193.92 Change $ -0.96 Change % -0.49 Tick N/A
Bid 193.03 Bid Size 100.00 Ask 195.00 Ask Size 100.00
Open 192.37 High 194.90 Low 192.11 Prev Close 194.88
Last Trade Volume 2.6 mi 52 Wk Hi 201.23 52 Wk Low 163.31
Market Cap 128.3 bi Ex-Div Date Div Rate 5.28 Yield 2.7230
Shares 661,706,007.00 EPS (TTM) 3.15 PE Ratio 61.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 45 74
Number of Buys 23 31
Number of Sells 22 43
Net Activity -8304 75103
Last 10 Buys Shares
Fred Hassan 1,000
Fred Hassan 1,000
Frank C. Herringer 1,000
Frank C. Herringer 1,000
Robert A. Bradway 1,000
Last 10 Sell Shares
Sean Harper 1,000
Sean Harper 1,000
Sean Harper 1,000
Sean Harper 1,000
Sean Harper 1,000
Sean Harper 1,000
Sean Harper 1,000
Sean Harper 1,000
De Francois Carbonnel 1,000
Sean Harper 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 224 224 224 224
Low Target Price Estimate 165 165 165 165
Mean Target Price Estimate 193.94 193.94 193.12 193.94
Standard Deviation 15.01 15.01 14.92 15.01
Date of Most Recent Estimate 06/03/18 05/22/18 05/22/18 06/03/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 1
Hold 12 13 14 14
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.22 2.26 2.3 2.3